Abstract
Two new cyclometalated Ru(II)-β-carboline complexes, [Ru(dmb)2(Cl-Ph-βC)](PF6) (dmb = 4,4′-dimethyl-2,2′-bipyridine; Cl-Ph-βC = Cl-phenyl-9H-pyrido[3,4-b]indole; RuβC-3) and [Ru(bpy)2(Cl-Ph-βC)](PF6) (bpy = 2,2′-bipyridine; RuβC-4) were synthesized and characterized. The Ru(II) complexes display high cytotoxicity against HeLa cells, the stabilized human cervical cancer cell, with IC50 values of 3.2 ± 0.4 μM (RuβC-3) and 4.1 ± 0.6 μM (RuβC-4), which were considerably lower than that of non-cyclometalated Ru(II)-β-carboline complex [Ru(bpy)2(1-Py-βC)] (PF6)2 (61.2 ± 3.9 μM) by 19- and 15-folds, respectively. The mechanism studies indicated that both Ru(II) complexes could significantly inhibit HeLa cell migration and invasion, and effectively induce G0/G1 cell cycle arrest. The new Ru(II) complexes could also trigger apoptosis through activating caspase-3 and poly (ADP-ribose) polymerase (PARP), increasing the Bax/Bcl-2 ratio, enhancing reactive oxygen species (ROS) generation, decreasing mitochondrial membrane potential (MMP), and inducing cytochrome c release from mitochondria. Further research revealed that RuβC-3 could deactivate the ERK/Akt signaling pathway thus inhibiting HeLa cell invasion and migration, and inducing apoptosis. In addition, RuβC-3-induced apoptosis in HeLa cells was closely associated with the increase of intracellular ROS levels, which may act as upstream factors to regulate ERK and Akt pathways. More importantly, RuβC-3 exhibited low toxicity on both normal BEAS-2B cells in vitro and zebrafish embryos in vivo. Consequently, the developed Ru(II) complexes have great potential on developing novel low-toxic anticancer drugs.
Graphic Abstract
Similar content being viewed by others
References
Nakisige C, Schwartz M, Ndira AO (2017) Gynecol Oncol Rep 20:37–40
Wu Q, Zheng K, Liao S, Ding Y, Li Y, Mei W (2016) Organometallics 35:317–326
Kümler I, Stenvang J, Moreira J, Brünner N, Nielsen DL (2015) Expert Rev Anticancer Ther 15:1075–1092
Poole VL, McCabe CJ (2015) J Endocrinol 227:R1–R12
Che CM, Huang JS (2002) Coord Chem Rev 231:151–164
Mjos KD, Orvig C (2014) Chem Rev 114:4540–4563
Antonarakis ES, Emadi A (2010) Cancer Chemother Pharmacol 66:1–9
Hartinger CG, Jakupec MA, Zorbas-Seifried S, Groessl M, Egger A, Berger W, Zorbas H, Dyson PJ, Keppler BK (2008) Chem Biodivers 5:2140–2155
Heffeter P, Böck K, Atil B, Reza Hoda MA, Körner W, Bartel C, Jungwirth U, Keppler BK, Micksche M, Berger W, Koellensperger G (2010) J Biol Inorg Chem 15:737–748
Monro S, Colón KL, Yin H, Roque J, Konda P, Gujar S, Thummel RP, Lilge L, Cameron CG, McFarland SA (2019) Chem Rev 119:797–828
Pisani MJ, Fromm PD, Mulyana Y, Clarke RJ, Körner H, Heimann K, Collins JG, Keene FR (2011) ChemMedChem 6:848–858
Ke H, Wang H, Wong W, Mak N, Kwong DWJ, Wong K, Tam H (2010) Chem Commun 46:6678–6680
Kou J, Qian C, Wang J, Chen X, Wang L, Chao H, Ji L (2012) J Biol Inorg Chem 17:81–96
Manning BD, Cantley LC (2007) Cell 129:1261–1274
Gottlieb TM, Leal JFM, Seger R, Taya Y, Oren M (2002) Oncogene 21:1299–1303
Bacus SS, Gudkov AV, Lowe M, Lyass L, Yung Y, Komarov AP, Keyomarsi K, Yarden Y, Seger R (2001) Oncogene 20:147–155
Tang D, Wu D, Hirao A, Lahti JM, Liu L, Mazza B, Kidd VJ, Mak TW, Ingram AJ (2002) J Biol Chem 277:12710–12717
Airaksinen MM, Kari I (1981) Med Biol 59:21–34
Cao R, Peng W, Chen H, Ma Y, Liu X, Hou X, Guan H, Xu A (2005) Biochem Biophys Res Commun 338:1557–1563
Xiao S, Wei L, Wang C, Yang M (2001) Bioorg Med Chem Lett 11:437–441
Zhao Y, Lv J, Chen J, Jin X, Wang M, Su Z, Wang L, Zhang H (2016) Prostate Cancer Prostatic Dis 19:358–366
Lai H, Zhao Z, Li L, Zheng W, Chen T (2015) Metallomics 7:439–447
Chen J, Peng F, Zhang Y, Li B, She J, Jie X, Zou Z, Chen M, Chen L (2017) Eur J Med Chem 140:104–117
Dong J, Shi X, Yan J, Xing J, Zhang Q, Xiao S (2010) Eur J Org Chem 2010:6987–6992
Sullivan BP, Salmon DJ, Meyer TJ (1978) Inorg Chem 17:3334–3341
Chen J, Zhang Y, Li G, Peng F, Jie X, She J, Dongye G, Zou Z, Rong S, Chen L (2018) J Biol Inorg Chem 23:261–275
Chen L, Li G, Peng F, Jie X, Dongye G, Cai K, Feng R, Li B, Zeng Q, Lun K, Chen J, Xu B (2016) Oncotarget 7:80716–80734
Collin JP, Sauvage JP (1986) Inorg Chem 25:135–141
Tan C, Lai S, Wu S, Hu S, Zhou L, Chen Y, Wang M, Zhu Y, Lian W, Peng W, Ji L, Xu A (2010) J Med Chem 53:7613–7624
Huang H, Zhang P, Yu B, Chen Y, Wang J, Ji L, Chao H (2014) J Med Chem 57:8971–8983
Velozo Sá VS, Pereira LR, Lima AP, Mello Andrade F, Rezende MR, Goveia RM, Pires WC, Silva MM, Oliveira KM, Ferreira AG (2019) Dalton Trans 48:6026–6039
Wyatt RA, Trieu NPV, Crawford BD (2017) Genes 8:1–17
Zeng Z, Wu Q, Sun F, Zheng K, Mei W (2016) Inorg Chem 55:5710–5718
Ma L, Lin X, Li C, Xu Z, Chan CY, Tse MK, Shi P, Zhu G (2018) Inorg Chem 57:2917–2924
Guha Majumdar A, Subramanian M (2019) Biochem Pharmacol 166:274–291
Liu P, Du R, Yu X (2019) Med Sci Monit 25:1283–1290
Wang M, Du Y, Huang H, Zhu Z, Du S, Chen S, Zhao H, Yan Z (2019) Acta Pharmacol Sin 40:522–529
Mao Z, Shen X, Dong P, Liu G, Pan S, Sun X, Hu H, Pan L, Huang J (2019) Phytomedicine 61:1–9
Xie H, Li X, Chen Y, Lang M, Shen Z, Shi L (2019) J Ethnopharmacol 231:230–240
Yang J, Chen L, Yan Y, Qiu J, Chen J, Song J, Rao Q, Ben David Y, Li Y, Hao X (2019) Biomed Pharmacother 112:1–7
Jiang G, Yao J, Wang J, Li W, Han B, Xie Y, Lin G, Huang H, Liu Y (2014) New J Chem 38:2554–2563
Zhou R, Yazdi AS, Menu P, Tschopp J (2011) Nature 469:221–225
Muro Small ML, Yarnell JE, McCusker CE, Castellano FN (2012) Eur J Inorg Chem 2012:4004–4011
Zhao C, Gao W, Chen T (2014) Apoptosis 19:668–681
Katrin Henze WM (2003) Nature 426:127–128
McBride HM, Neuspiel M, Wasiak S (2006) Curr Biol 16:R551–R560
Yugandhar D, Nayak VL, Archana S, Shekar KC, Srivastava AK (2015) Eur J Med Chem 101:348–357
Zhou J, Zhang S, Ong CN, Shen HM (2006) Biochem Pharmacol 72:132–144
Yang X, Chen L, Liu Y, Yang Y, Chen T, Zheng W, Liu J, He QY (2012) Biochimie 94:345–353
Lufen Chang MK (2001) Nature 410:37–40
Noguchi S, Yasui Y, Iwasaki J, Kumazaki M, Yamada N, Naito S, Akao Y (2013) Cancer Lett 328:353–361
Park KR, Nam D, Yun HM, Lee SG, Jang HJ, Sethi G, Cho SK, Ahn KS (2011) Cancer Lett 312:178–188
Shih A, Davis FB, Lin H-Y, Davis PJ (2002) J Clin Endocrinol Metab 87:1223–1232
Kim YH, Lee DH, Jeong JH, Guo ZS, Lee YJ (2008) Biochem Pharmacol 75:1946–1958
Tewari R, Sharma V, Koul N, Sen E (2008) J Neurochem 107:616–627
Zhou B, Huang Y, Yang F, Zheng W, Chen T (2016) Chem Asian J 11:1008–1019
Luo Z, Yu L, Yang F, Zhao Z, Yu B, Lai H, Wong KH, Ngai SM, Zheng W, Chen T (2014) Metallomics 6:1480–1490
Zhao Z, Luo Z, Wu Q, Zheng W, Feng Y, Chen T (2014) Dalton Trans 43:17017–17028
Li M, Lai L, Zhao Z, Chen T (2016) Chem Asian J 11:310–320
Cadenas E, Davies KJA (2000) Free Radical Biol Med 29:222–230
Simon HU, HajYehia A, LeviSchaffer F (2000) Apoptosis 5:415–418
Doering M, Ba LA, Lilienthal N, Nicco C, Scherer C, Abbas M, Zada AAP, Coriat R, Burkholz T, Wessjohann L, Diederich M, Batteux F, Herling M, Jacob C (2010) J Med Chem 53:6954–6963
Aroui S, Dardevet L, Ajmia WB, de Boisvilliers M, Perrin F, Laajimi A, Boumendjel A, Kenani A, Muller JM, De Waard M (2015) Mol Pharm 12:4336–4348
Deng Z, Gao P, Yu L, Ma B, You Y, Chan L, Mei C, Chen T (2017) Biomaterials 129:111–126
Seo HH, Kim SW, Lee CY, Lim KH, Lee J, Lim S, Lee S, Hwang KC (2017) Eur J Pharmacol 798:35–42
Shingyochi Y, Kanazawa S, Tajima S, Tanaka R, Mizuno H, Tobita M (2017) PLoS ONE 12:e0168937–e0168950
Cao W, Zheng W, Chen T (2015) Sci Rep 5:1–11
Chen L, Peng F, Li G, Jie X, Cai K, Cai C, Zhong Y, Zeng H, Li W, Zhang Z, Chen J (2016) J Inorg Biochem 156:64–74
Tan C, Wu S, Lai S, Wang M, Chen Y, Zhou L, Zhu Y, Lian W, Peng W, Ji L, Xu A (2011) Dalton Trans 40:8611–8621
Qian C, Wang J, Song C, Wang L, Ji L, Chao H (2013) Metallomics 5:844–854
Huang H, Zhang P, Chen H, Ji L, Chao H (2015) Chem Eur J 21:715–725
Chen J, Zhang Y, Li B, Li G, Jie X, Cui Y, Zou Z, Huang X, Qu J, Chen L (2018) Transit Metal Chem 43:149–159
Acknowledgements
This work was supported by the National Natural Science Foundation of China (21701034), the Natural Science Foundation of Guangdong Province (2020A1515010444), the Science and technology program of Guangdong Province (2019B090905011), Discipline Construction Project of Guangdong Medical University (4SG21004G), the Fund of Southern Marine Science and Engineering Guangdong Laboratory (Zhanjiang) (ZJW-2019-007), Major Scientific Research Project in Guangdong Province (Special Innovative Project) (2018KQNCX100), the Medical Scientific Research Foundation of Guangdong Province of China (A2020414), and the University Student Innovation Experiment Program.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Chen, J., Deng, Y., Wang, J. et al. Cyclometalated Ru(II) β-carboline complexes induce cell cycle arrest and apoptosis in human HeLa cervical cancer cells via suppressing ERK and Akt signaling. J Biol Inorg Chem 26, 793–808 (2021). https://doi.org/10.1007/s00775-021-01894-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-021-01894-4